Tenafly, NJ – According to filings with the U.S. Securities and Exchange Commission, IntraBio is raising $21,000,000.00 in new funding. Sources indicate as part of senior management Chairman, Mallory Factor played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About IntraBio

IntraBio is a biopharmaceutical company with a late-stage drug pipeline that includes novel treatments for genetic and neurodegenerative diseases. Our clinical programs leverage the expertise of our scientific founders from the University of Oxford and University of Munich, the preeminent experts and pioneers in discovering and developing small molecule drugs that modulate lysosomal function and intracellular calcium signaling.

To learn more about IntraBio, visit http://intrabio.com/

Contact:
Mallory Factor, Chairman
877-386-7402
https://www.linkedin.com/in/malloryfactor/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved